LEXINGTON, Ky. (Nov. 19, 2020) – The statistics on Alzheimer’s and dementia inducing brain disease are frightening to look at, and unlike research into cancer and heart disease, researchers have often been frustrated in their efforts to make progress in understanding these diseases.
Dr. Peter Nelson, of the University of Kentucky’s Sanders-Brown Center on Aging, has spent the last 15 years in the Commonwealth helping to lead the fight against Alzheimer’s and dementia inducing brain disease. “Clinical trials are where we’re going to make the difference in Alzheimer’s disease and dementia research,” says Nelson. “My colleagues who do the clinical trials do the most clinical trials of anybody in the country. More than Harvard, more than Stanford, more than U. Chicago, the very best in the world. So, if people want to be involved in clinical trial research, this is the place they go.”
On this episode of Behind the Blue, UKPR’s Carl Nathe talks with Nelson about the work of the Sanders-Brown Center on Aging, the strategies involved in working with such a complex set of diseases, the personal experience that drives his efforts in this research, and more.
"Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university.
For questions or comments about this or any other episode of "Behind the Blue," email BehindTheBlue@uky.edu or tweet your question with #BehindTheBlue.
To discover what’s wildly possible at the University of Kentucky, click here.